Resources

Publish Date
Infographics & Fact Sheets
PREVAIL in Comparison to the Current and Previous Administration’s Procedures for PTAB
Public Comments
C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
Letters
C4IP Letter to Senate and House IP Subcommittees RE: Designating October as National IP Month
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: PERA Hearing
Public Comments
C4IP Comments RE: U.K. IPO Consultation on SEPs
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences

The Patent Eligibility Restoration Act of 2025 (PERA), sponsored by Sens. Thom Tillis (R-NC) and Chris Coons (D-DE), is bipartisan legislation that...

Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Artificial Intelligence
Letters
C4IP Letter to FTC & DOJ RE: Drug Pricing Listening Sessions
Infographics & Fact Sheets
Drug Competition Enhancement Act Infographic
Infographics & Fact Sheets
Affordable Prescriptions for Patients Act Infographic
Resources:

Resources:

PREVAIL in Comparison to the Current and Previous Administration’s Procedures for PTAB,

11/17/2025

Resources:

Resources:

C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime,

11/06/2025

Resources:

Resources:

C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004),

11/03/2025

C4IP:

C4IP, Resources:

C4IP Letter to Senate and House IP Subcommittees RE: Designating October as National IP Month,

10/21/2025

Resources:

Resources:

C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: PERA Hearing,

10/07/2025

Resources:

Resources:

C4IP Comments RE: U.K. IPO Consultation on SEPs,

10/03/2025

Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology,

09/25/2025

Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences,

09/25/2025

Resources:

Resources:

C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Artificial Intelligence,

09/18/2025

Resources:

Resources:

C4IP Letter to FTC & DOJ RE: Drug Pricing Listening Sessions,

08/15/2025

Resources:

Resources:

Drug Competition Enhancement Act Infographic,

06/27/2025

Resources:

Resources:

Affordable Prescriptions for Patients Act Infographic,

06/27/2025

Scroll to Top